Carl Goldfischer - Net Worth and Insider Trading
Carl Goldfischer Net Worth
The estimated net worth of Carl Goldfischer is at least $5 Million dollars as of 2025-01-16. Carl Goldfischer is the Director of Epizyme Inc and owns about 3,385,951 shares of Epizyme Inc (EPZM) stock worth over $5 Million. Carl Goldfischer is also the Director of CymaBay Therapeutics Inc and owns about 0 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $0. Details can be seen in Carl Goldfischer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Goldfischer has not made any transactions after 2020-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carl Goldfischer
Carl Goldfischer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl Goldfischer owns 7 companies in total, including Epizyme Inc (EPZM) , Imara Inc (IMRA) , and CymaBay Therapeutics Inc (CBAY) among others .
Click here to see the complete history of Carl Goldfischer’s form 4 insider trades.
Insider Ownership Summary of Carl Goldfischer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EPZM | Epizyme Inc | 2020-11-11 | director |
| IMRA | Imara Inc | 2020-03-11 | director & 10 percent owner |
| CBAY | CymaBay Therapeutics Inc | 2019-02-07 | director |
 | | 2017-05-25 | director |
| | 2011-06-09 | director |
| | 2020-10-28 | director |
| | 2020-03-11 | director & 10 percent owner |
Carl Goldfischer Latest Holdings Summary
Carl Goldfischer currently owns a total of 2 stocks. Among these stocks, Carl Goldfischer owns 3,385,951 shares of Epizyme Inc (EPZM) as of November 11, 2020, with a value of $5 Million and a weighting of 100%. Carl Goldfischer also owns 0 shares of CymaBay Therapeutics Inc (CBAY) as of February 7, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Carl Goldfischer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EPZM | Epizyme Inc | 2020-11-11 | 3,385,951 | 1.47 | 4,977,348 |
| CBAY | CymaBay Therapeutics Inc | 2019-02-07 | 0 | 32.48 | 0 |
Holding Weightings of Carl Goldfischer
Carl Goldfischer Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl Goldfischer has made a total of 1 transactions in Epizyme Inc (EPZM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Epizyme Inc is the acquisition of 5,000 shares on November 11, 2020, which cost Carl Goldfischer around $60,350.
According to the SEC Form 4 filings, Carl Goldfischer has made a total of 0 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years. The most-recent trade in CymaBay Therapeutics Inc is the sale of 11,675 shares on February 7, 2019, which brought Carl Goldfischer around $105,309.
Insider Trading History of Carl Goldfischer
- 1
Carl Goldfischer Trading Performance
GuruFocus tracks the stock performance after each of Carl Goldfischer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl Goldfischer is 9.23%. GuruFocus also compares Carl Goldfischer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl Goldfischer within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carl Goldfischer's insider trading performs compared to the benchmark.
Performance of Carl Goldfischer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.79 | | | | | |
| Relative Return to S&P 500(%) | 5.74 | | | | | |
Carl Goldfischer Ownership Network
Ownership Network List of Carl Goldfischer
Ownership Network Relation of Carl Goldfischer
Carl Goldfischer Owned Company Details
What does Epizyme Inc do?
Who are the key executives at Epizyme Inc?
Carl Goldfischer is the director of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .
Epizyme Inc (EPZM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Epizyme Inc Insider Transactions
Carl Goldfischer Mailing Address
Above is the net worth, insider trading, and ownership report for Carl Goldfischer. You might contact Carl Goldfischer via mailing address: 161 West 61st Street, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
